Cargando…
A two-step mechanism governing PARP1-DNA retention by PARP inhibitors
PARP inhibitors (PARPi) have emerged as promising cancer therapeutics capable of targeting specific DNA repair pathways, but their mechanism of action with respect to PARP1-DNA retention remains unclear. Here, we developed single-molecule assays to directly monitor the retention of PARP1 on DNA lesi...
Autores principales: | Xue, Huijun, Bhardwaj, Amit, Yin, Yandong, Fijen, Carel, Ephstein, Anastasiya, Zhang, Lianglin, Ding, Xia, Pascal, John M., VanArsdale, Todd L., Rothenberg, Eli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9451145/ https://www.ncbi.nlm.nih.gov/pubmed/36070389 http://dx.doi.org/10.1126/sciadv.abq0414 |
Ejemplares similares
-
Clinical PARP inhibitors allosterically induce PARP2 retention on DNA
por: Langelier, Marie-France, et al.
Publicado: (2023) -
PARP14 is a PARP with both ADP-ribosyl transferase and hydrolase activities
por: Đukić, Nina, et al.
Publicado: (2023) -
Single-virus tracking reveals variant SARS-CoV-2 spike proteins induce ACE2-independent membrane interactions
por: Christie, Shaun M., et al.
Publicado: (2022) -
PARP1-SNAI2 transcription axis drives resistance to PARP inhibitor, Talazoparib
por: Ding, Xia, et al.
Publicado: (2022) -
Nimbolide targets RNF114 to induce the trapping of PARP1 and synthetic lethality in BRCA-mutated cancer
por: Li, Peng, et al.
Publicado: (2023)